Author:
Duan Zi-Hao,He Chun-Yuan,Chen Jie,Jiang Jun-Jie,Zhixiang Zhu,Li Jing,Wang Fa-Cai
Reference35 articles.
1. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies;P N Patsalos;Epilepsia,2008
2. Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update;P N Patsalos;Ther Drug Monit,2018
3. Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data;M J Blanco-Serrano1;Biopharm Drug Dispos,1999
4. Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model;Shenghui Mei;Eur J Clin Pharmaco,2018
5. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy;Yingjie Guo;Drug Metab Pharmacokinet,2012